MedPath

KANSAI MEDICAL UNIVERSITY

🇯🇵Japan
Ownership
Private
Established
1928-01-01
Employees
-
Market Cap
-
Website
http://www.kmu.ac.jp

Clinical Trials

138

Active:0
Completed:79

Trial Phases

4 Phases

Phase 1:4
Phase 2:5
Phase 3:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (137 trials with phase data)• Click on a phase to view related trials

Not Applicable
127 (92.7%)
Phase 2
5 (3.6%)
Phase 1
4 (2.9%)
Phase 3
1 (0.7%)

Characterization of Macroprolactinemia

Completed
Conditions
Hyperprolactinemia
First Posted Date
2007-02-16
Last Posted Date
2007-02-16
Lead Sponsor
Kansai Medical University
Registration Number
NCT00436111
Locations
🇯🇵

Kansai Medical University, Osaka, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.